Affordable Access

Antimutagenic activity of afobazole in various regimens of treatment.

Authors
Type
Published Article
Journal
Bulletin of experimental biology and medicine
Publication Date
Volume
130
Issue
11
Pages
1077–1079
Identifiers
PMID: 11182820
Source
Medline
License
Unknown

Abstract

The influence of a new 2-mercaptobenzimidazole derivative afobazole on cytogenetic effects of dioxidine and cyclophosphamide was studied by counting chromosome aberrations in bone marrow cells of C57Bl/6 mice. Afobazole (1-100 mg/kg perorally) exhibited antimutagenic activity determined by its antioxidant properties. This activity depended on the dose and treatment schedule.

Statistics

Seen <100 times